GTS Securities’s Immunogen Inc IMGN Stock Holding History

GTS Securities’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,199	Closed	-$194K	–	4512
2023 Q3	$194K	Buy	+12,199	New	+$203K	﹤0.01%	3424

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GTS Securities's IMGN Position: Q4 2023 in Review

GTS Securities sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 12,199 shares — an estimated $194K sold.

GTS Securities first reported a position in IMGN in Q3 2023 and held it in 1 quarter. The position peaked at $194K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

GTS Securities reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
GTS Securities sold 12,199 Immunogen Inc shares in Q4 2023, an estimated $194K.
GTS Securities first reported a position in Immunogen Inc in Q3 2023 and held it in 1 quarter.
GTS Securities's Immunogen Inc position peaked at $194K in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on GTS Securities's 13F filing for Q4 2023, filed 15 Feb 2024.